Novartis AG (ADR) news

   Watch this stock
Showing stories 11 - 20 of about 180   

Articles published

NVS 84.99 -0.44 (-0.51%)
price chart
Is there a Bearish outlook for Novartis AG (ADR) (NYSE:NVS) this week?
Among 14 analysts covering Novartis Ag (NYSE:NVS), 4 have Buy rating, 2 Sell and 8 Hold. Therefore 29% are positive. Novartis Ag had 22 analyst reports since July 28, 2015 according to SRatingsIntel. The company was upgraded on Wednesday, March 8 ...
Novartis AG (ADR) (NVS) Analysts See $1.18 EPS  WeeklyHub
Bradley Foster & Sargent INC Has Lowered Its Position in Novartis AG Adr (NVS ...
Bradley Foster & Sargent Inc decreased its stake in Novartis A G Adr (NVS) by 45.21% based on its latest 2016Q4 regulatory filing with the SEC.
Novartis AG (ADR) (NVS) Reaches $82.81 After 4.00% Up Move; Entegra ...  Key Gazette
As Novartis Adr (NVS) Share Value Rose, Headinvest Increased by $369360 Its ...
Headinvest Llc who had been investing in Novartis Adr for a number of months, seems to be bullish on the $223.75B market cap company.
Earnings Scheduled For July 18, 2017
Novartis AG (ADR) (NYSE: NVS) is projected to report quarterly earnings at $1.18 per share on revenue of $12.25 billion.
Kames Capital Plc Raised Trimble (TRMB) Stake; Boston Common Asset Management ...
Boston Common Asset Management Llc decreased Novartis A G Sponsored Adr (NVS) stake by 13.94% reported in 2016Q4 SEC filing.
Cardinal Capital Management Decreased Its Novartis Adr (NVS) Position by ...
Cardinal Capital Management who had been investing in Novartis Adr for a number of months, seems to be less bullish one the $223.49B market cap company.
Is Pioneer Natural Resources Company (NYSE:PXD) Undervalued?  Normangee Star
22 Stocks Moving In Tuesday's Pre-Market Session
Novartis AG (ADR) (NYSE: NVS) gained 3 percent to $85.76 after the company posted upbeat quarterly profit. Lockheed Martin Corporation (NYSE: LMT) shares rose 2.6 percent to $296.00 in pre-market trading after the company reported upbeat quarterly ...
Novartis AG (NYSE:NVS) Short Interest Decreased By 11.18%
Among 15 analysts covering Novartis Ag (NYSE:NVS), 4 have Buy rating, 3 Sell and 8 Hold. Therefore 27% are positive. Novartis Ag had 26 analyst reports since July 28, 2015 according to SRatingsIntel.
Novartis AG (ADR) (NYSE:NVS) To Face FDA Panel For Cancer Treatment, Kite ...
Novartis AG (ADR) (NYSE:NVS) is scheduled for a vital FDA panel meeting regarding its pipeline cancer treatment. The panel review is expected to take place later this month and Kite Pharma Inc (NASDAQ:KITE) might benefit heavily.
Amg National Trust Bank Cut By $801576 Its Novartis AG Sponsored Adr (NVS ...
Amg National Trust Bank decreased Novartis A G Sponsored Adr (NVS) stake by 8.04% reported in 2016Q4 SEC filing. Amg National Trust Bank sold 11,133 shares as Novartis A G Sponsored Adr (NVS)'s stock rose 4.17%. The Amg National Trust Bank ...